Beta cell failure in T1D
Mitochondrial dysfunction in T1D : Potential future targeted therapy
Epigenetic changes in T1D and future hypomethylating agents
1-Translational researches in T1DM : from molecular biology to clinical medicine
2-Molecular mechanisms of etiopathogenesis and complications of T1D
3-Novel molecular immunogenetics of T1D
4-Gut microbiota changes in T1D
5-New molecular biomarkers of T1D and its complications
6-CGM and meticulous control of T1D
8-Mesenchymal stem cell therapy : potential benefits of Bio-nanotechnology
9-The future of improving insulin technologies
10-Prospects for effective preventive strategies of T1D
Dr. Hassan Abdelwahed abdalla Shora
Manuscripts should be submitted via our online editorial system at https://jour.ipublishment.com/imr/access/login by registering and logging in to this website. Once you are registered, click here to start your submission Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted papers should be well formatted and use good English.